Month: March 2023

Aqua Metals Reports 2022 Financial Results

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

Commissioning of Lithium Pilot Plant in Reno, Securing of Future Commercial Site, Drive Optimism for 2023 and Beyond RENO, Nev., March 09, 2023 (GLOBE NEWSWIRE) — Aqua Metals, Inc. (NASDAQ: AQMS) (“Aqua Metals” or the “Company”), which is reinventing metals recycling with its AquaRefining™ technology, today announced financial results and provided a business update for the fourth quarter and full-year period ended December 31, 2022. Recent Highlights:Aqua Metals ended the year with $7.1 million in cash and $10.9 million in working capital. Management expects to receive an additional $12 million by the end of March 2023 related to the sale of its former Tahoe-Reno facility. Aqua Metals commissioned its recycling pilot operation at its Innovation Center in Tahoe-Reno Industrial Center during the fourth quarter...

TTM Technologies, Inc. Announces Sale of Shanghai Backplane Assembly Facility

Written by Customer Service on March 9, 2023. Posted in Mergers And Acquisitions.

SANTA ANA, Calif., March 09, 2023 (GLOBE NEWSWIRE) — TTM Technologies, Inc. (NASDAQ: TTMI), a leading global manufacturer of technology solutions including engineered systems, radio frequency (“RF”) components and RF microwave/microelectronic assemblies and printed circuit boards (“PCB”s), today announced that that it has signed a definitive agreement to sell its Shanghai Backplane Assembly (“BPA”) for approximately $11.8 million, subject to customary post-closing adjustments, to DBG Holdings Limited (“DBG”), which is wholly owned by DBG Technology Co, Ltd., a public company traded on the Shenzhen Stock Exchange. We expect this transaction to close near the end of the first quarter. BPA is a small assembly facility that generated $44.7 million in revenues and an immaterial amount of operating income in 2022. This transaction is...

Alto Ingredients, Inc. Reports Fourth Quarter and Full Year 2022 Results

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

– Growth, Revenue Diversification and Efficiency Initiatives to Expand Annualized EBITDA by Over $65 Million by the End of 2025 and Over $125 Million by the End of 2026 – PEKIN, Ill., March 09, 2023 (GLOBE NEWSWIRE) — Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer and distributor of specialty alcohols and essential ingredients, reported its fourth quarter and full year 2022 financial results for the year ended December 31, 2022. “Alto has been executing a series of growth initiatives to diversify our revenue streams, maximize our high-margin products, and optimize our operations to continue our business transformation,” said Mike Kandris, CEO of Alto Ingredients. “Our efforts are coming to fruition. Our specialty alcohol infrastructure upgrades are complete, and we are excited to introduce our new high-quality...

Logan Ridge Finance Corporation Announces Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

Reports a Strong Fourth Quarter with Net Investment Income of $0.23 Per Share, Which Marks its Second Consecutive Quarter of Positive Net Investment Income and More Than Triples the Net Investment Income Reported in the Prior Quarter Restores Quarterly Distribution; Announces $0.18 Per Share Distribution for the First Quarter of 2023 Board of Directors Authorizes a $5.0 Million Share Repurchase Program NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) — Logan Ridge Finance Corporation (“Logan Ridge”, “LRFC” or the “Company”) (Nasdaq: LRFC) announced today its financial results for the fourth quarter and full year ended December 31, 2022. Fourth Quarter 2022 HighlightsReported positive Net Investment Income (“NII”) of $0.6 million or $0.23 per share, which marks the Company’s second consecutive quarter of positive NII. Net asset value...

Oil-Dri Announces Record Sales for the Second Quarter and First Six-Months of Fiscal Year 2023

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

CHICAGO, March 09, 2023 (GLOBE NEWSWIRE) — Oil-Dri Corporation of America (NYSE: ODC), producer and marketer of sorbent mineral products, today announced results for its second quarter and first six-months of fiscal year 2023. Second Quarter Year to Date(in thousands, except per share amounts) Ended January 31, Ended January 31, 2023 2022 Change 2023 2022 ChangeConsolidated Results Net Sales $101,669 $87,210 17 % $200,208 $169,670 18 %Net Income Attributable to Oil-Dri $3,856 $2,002 93 % $9,097 $2,587 252 %Net Income Attributable to Oil-Dri Excluding Landfill Modification† $5,833 $2,002 191 % $11,074 $2,587 328 %Earnings per Common Diluted Share $0.56 $0.28 100 % $1.34 $0.37 262 %Earnings per Common Diluted Share Excluding Landfill Modification† $0.85 $0.28 204 % $1.63 $0.37 341 %Business...

Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Highlights

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

– On Track to Provide Initial Clinical Data from Gene Editing Trial for PKU Mid-Year with First Participant Dosed and Others in Screening – – Initial Clinical Data from Gene Therapy Trial for Hunter Syndrome Anticipated in Second Half of 2023; Trial Recruiting in the U.S. and Canada – – Anticipated Cash Runway Into Fourth Quarter 2024 Enables Execution Against Key Milestones – BEDFORD, Mass., March 09, 2023 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today financial results for the fourth quarter and full year ended December 31, 2022, and highlighted recent accomplishments. “We entered 2023 with strong momentum across our gene editing and gene therapy clinical trials for PKU and Hunter syndrome, and we anticipate initial data read-outs from...

Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

— Preliminary data from GRANITE Phase 2/3 study (individualized vaccine for first-line microsatellite-stable colorectal cancer [MSS-CRC]) remain expected in 4Q 2023 — — Phase 1/2 efficacy signals from “off-the-shelf” vaccine program (SLATE) consistent with those from GRANITE; randomized study of SLATE in patients with newly-diagnosed metastatic cancer to initiate in 2H 2023 — — Clinical evidence building for differentiation of self-amplifying mRNA (samRNA) as a potential next-gen mRNA platform in infectious disease — — Cash, cash equivalents, marketable securities, and restricted cash of $185.2 million as of December 31, 2022 — — Gritstone to host conference call today at 4:30pm ET — EMERYVILLE, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS),...

Clearside Biomedical Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

– Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2 2023 – – Medical Meeting Presentations Highlight Significant Potential of CLS-AX Based on Positive OASIS Phase 1/2a Safety Data, Durability, and Biologic Effect Over 6 Months – – Continued Growth in Retinal Specialists Trained in Suprachoroidal Space (SCS®) Injection Procedure Using FDA-Approved XIPERE® – – Management to Host Webcast and Conference Call Today at 4:30 P.M. ET – ALPHARETTA, Ga., March 09, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today reported financial results for the fourth quarter and year ended December 31, 2022 and provided a corporate...

AvePoint Announces Fourth Quarter and Full Year 2022 Financial Results

Written by Customer Service on March 9, 2023. Posted in Earnings Releases And Operating Results.

Full year SaaS revenue of $117.2 million, representing 37% year-over-year growth, 46% adjusted for constant currencyFull year total revenue of $232.3 million, representing 21% year-over-year growth, 29% adjusted for constant currencyTotal ARR of $201.7 million, representing 27% year-over-year growth, 32% adjusted for FX impact JERSEY CITY, N.J., March 09, 2023 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the most advanced platform to optimize SaaS operations and secure collaboration, today announced financial results for the fourth quarter and full year ended December 31, 2022. “Our fourth quarter results were a strong close to 2022, highlighted by 32% ARR growth and 26% revenue growth, both adjusted for the impact of FX,” said Dr. Tianyi Jiang (TJ), CEO and Co-Founder of AvePoint. “Despite an uncertain macro environment, our strong...

New York Mortgage Trust Declares First Quarter 2023 Common Stock Dividend of $0.40 Per Share, and Preferred Stock Dividends

Written by Customer Service on March 9, 2023. Posted in Dividend Reports And Estimates.

NEW YORK, March 09, 2023 (GLOBE NEWSWIRE) — New York Mortgage Trust, Inc. (Nasdaq: NYMT) (the “Company”) announced today that its Board of Directors (the “Board”) declared a regular quarterly cash dividend of $0.40 per share on shares of its common stock for the quarter ending March 31, 2023. The dividend will be payable on April 26, 2023 to common stockholders of record as of the close of business on March 20, 2023. In addition, the Board declared cash dividends on the Company’s 8.000% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series D Preferred Stock”), 7.875% Series E Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series E Preferred Stock”), 6.875% Series F Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (“Series F Preferred Stock”) and 7.000% Series G Cumulative Redeemable...

Month: March 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals